Elanco authorizes workforce restructuring with about $175 million in pretax charges
Elanco's board authorized a workforce restructuring plan on December 5, 2025, which is expected to eliminate about 300 positions and cost about $175 million in pretax charges, mostly in 2025. The company reaffirmed its fourth-quarter and full-year 2025 revenue and adjusted earnings guidance, but said its reported net loss and loss per share will reflect the charges, and it outlined a three-year financial outlook at its December 9 Investor Day.
Key points
- Plan covers about 300 eliminated positions and about 300 roles shifted to growth areas or lower-cost locations.
- Expected pretax charges total about $175 million: about $130 million cash-based, mostly paid over the next 2 years, and about $45 million non-cash asset impairments.
- Impairments relate to closing the Kansas City, Missouri implant facility and exiting part of the Monheim, Germany facility.
- Expected savings of about $25 million in 2026 and about $60 million in 2027; full-year 2025 revenue and adjusted earnings guidance reaffirmed.
The filing
Written by AI on Nov 8, 2026, 1:12 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on December 09, 2025.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.